Abstract
Neuron loss is a key feature of neurodegenerative diseases often leading to brain atrophy detectable through magnetic resonance imaging (MRI). Various brain atrophy measures are essential in research of Alzheimer’ disease (AD) and related dementias. This study aims to forecast future annual percentage changes in hippocampal, ventricular, and total gray matter (TGM) volumes in individuals with varying cognitive statuses, from healthy to dementia. We developed a machine learning model using elastic net linear regression and tested two approaches: (1) a baseline model using predictors from a single-time-point and (2) a longitudinal model using predictors derived from longitudinal MRI. Both approaches were evaluated with MRI-only models and models that combined MRI with additional risk factors (age, sex, APOE4, and baseline diagnosis). Cross-validated Pearson correlation scores between predicted and actual annual percentage changes were 0.62 for the hippocampus, 0.51 for the ventricles, and 0.41 for TGM, using the longitudinal MRI + risk factor model. Longitudinal models consistently outperformed baseline models, and models including risk factors outperformed the MRI only model. Validation using an external dataset confirmed these findings, highlighting the value of predictors derived based on longitudinal data. We further studied the value of the predicted atrophy/enlargement rates for clinical status progression prediction across three different datasets. Predicted atrophy was a consistently better indicator of progression to mild cognitive impairment and dementia than present-day regional volumes, with the longitudinal atrophy prediction model typically outperforming the baseline model in terms of clinical status prediction. Future atrophy prediction has significant potential for assessing the risk of cognitive decline, even in cognitively unimpaired individuals, and can aid in selecting participants for clinical trials of disease-modifying drugs for AD.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research has been supported by The Academy of Finland, grant 351849 under the frame of ERA PerMed (Pattern-Cog), grants 346934 (PRIMAL), and 358944 (Flagship of Advanced Mathematics for Sensing Imaging and Modeling) from the Research Council of Finland.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced are available online at http://adni.loni.usc.edu https://aibl.org.au
